Literature DB >> 26383899

Lupus Anticoagulant Positivity in Pediatric Patients With Prolonged Activated Partial Thromboplastin Time: A Single-Center Experience and Review of Literature.

Baris Malbora1, Eris Bilaloglu2.   

Abstract

The presence of lupus anticoagulants (LAs) is an important cause of activated partial thromboplastin time (aPTT) prolongation found in children after an infection or during screening tests before surgical intervention. The authors retrospectively reviewed the charts of 68 patients who have been consulted from surgery departments with prolonged aPTT. These patients were reevaluated with aPTT analysis after 1 week. Thirteen patients had normal aPTTs. Therefore, 55 patients remained with prolonged aPTTs. LA positivity was detected in 39 patients. Sixteen of these had prolonged aPTT prior to surgery (41%). Others with LA positivity had systemic lupus erythematosus (SLE; n = 6), infection (n = 5), leukemia (n = 3), hemolytic uremic syndrome (n = 2), epistaxis (n = 2), antiphospholipid syndrome (APS; n = 1), chronic immune thrombocytopenic purpura (n = 1), acute poststreptococcal glomerulonephritis (n = 1), central nervous system (CNS) thrombosis (n = 1), and congenital heart disease (n = 1). None of the patients had bleeding history. LA positivity rarely leads to bleeding and/or thrombosis. Specific therapy is usually not needed. Further prospective multicenter studies are required to understand clinical outcomes and laboratory correlation in children with positive LA.

Entities:  

Keywords:  activated partial thromboplastin time; bleeding; children; lupus anticoagulant; thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26383899     DOI: 10.3109/08880018.2015.1065302

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  2 in total

Review 1.  Patient blood management in India - Review of current practices and feasibility of applying appropriate standard of care guidelines. A position paper by an interdisciplinary expert group.

Authors:  Ajay Gandhi; Klaus Görlinger; Sukesh C Nair; Poonam M Kapoor; Anjan Trikha; Yatin Mehta; Anil Handoo; Anil Karlekar; Jyoti Kotwal; Joseph John; Shashikant Apte; Vijay Vohra; Gajendra Gupta; Aseem K Tiwari; Anjali Rani; Shweta A Singh
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-04-10

2.  Incorporation of Evidence-based Guidelines on Bleeding Risk Assessment Prior to Surgery into Practice: Real-time Experience.

Authors:  Nada Al-Marhoobi; Manar Maktoom; Mohamed Elshinawy; Hanan Nazir; Khalid Al Hashmi; Rashid Al-Abri; Khalil Macki; Abdulhakim Al-Rawas; Fatma AlBulushi; Yasser Wali; Doaa Khater
Journal:  Oman Med J       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.